proISG15 (2-165) Citations (2)

Originally described in: Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies.
Swatek KN, Aumayr M, Pruneda JN, Visser LJ, Berryman S, Kueck AF, Geurink PP, Ovaa H, van Kuppeveld FJM, Tuthill TJ, Skern T, Komander D Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2371-2376. doi: 10.1073/pnas.1710617115. Epub 2018 Feb 20. PubMed Journal

---

Articles Citing proISG15 (2-165)

Articles
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, Garcia-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. Front Pharmacol. 2021 Mar 23;12:633680. doi: 10.3389/fphar.2021.633680. eCollection 2021. PubMed
Identification and characterization of nanobodies specific for the human ubiquitin-like ISG15 protein. Gan J, Dabhade P, Wijne C, McKibben W, Draganov SD, Alrawili H, Sun ZJ, Houghton JW, Tate EW, Le Gall C, Suresh P, Pishesha N, Pinto-Fernandez A, Schwartz TU, Ploegh HL. J Biol Chem. 2025 Sep;301(9):110564. doi: 10.1016/j.jbc.2025.110564. Epub 2025 Aug 6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.